Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Vaccinex, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 22 | 25 | +3 |
| Shares | 4.61M | 4.69M | +74.5K (+1.6%) |
| Value | $2.28M | $3.12M | +$833.5K (+36.5%) |
New holders (5)
Institutions that held Vaccinex, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| UBS Group AG | 2,151 | $1.38K | 0.00% |
| Cornerstone Planning Group LLC | 200 | $122 | 0.00% |
| Money Concepts Capital Corp | 110 | $71 | 0.00% |
| Bank of America Corp | 54 | $34 | 0.00% |
| CWM, LLC | 300 | $0 | 0.00% |
Sold out (2)
Institutions that held Vaccinex, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 87,700 | $43.0K |
| Virtu Financial LLC | 10,370 | $5.00K |